These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9711782)

  • 21. Notwithstanding Circumstantial Alibis, Cytotoxic T Cells Can Be Major Killers of HIV-1-Infected Cells.
    Gadhamsetty S; Coorens T; de Boer RJ
    J Virol; 2016 Aug; 90(16):7066-7083. PubMed ID: 27226367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early HIV-1 envelope-specific cytotoxic T lymphocyte responses in vertically infected infants.
    Pikora CA; Sullivan JL; Panicali D; Luzuriaga K
    J Exp Med; 1997 Apr; 185(7):1153-61. PubMed ID: 9104802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in frequency of HIV-1-specific cytotoxic T cell precursors and circulating effectors after combination antiretroviral therapy in children.
    Spiegel HM; DeFalcon E; Ogg GS; Larsson M; Beadle TJ; Tao P; McMichael AJ; Bhardwaj N; O'Callaghan C; Cox WI; Krasinski K; Pollack H; Borkowsky W; Nixon DF
    J Infect Dis; 1999 Aug; 180(2):359-68. PubMed ID: 10395850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occurrence of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T cell activity in apparently uninfected children born to HIV-1-infected mothers.
    De Maria A; Cirillo C; Moretta L
    J Infect Dis; 1994 Nov; 170(5):1296-9. PubMed ID: 7963731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective role of beta-chemokines associated with HIV-specific Th responses against perinatal HIV transmission.
    Wasik TJ; Bratosiewicz J; Wierzbicki A; Whiteman VE; Rutstein RR; Starr SE; Douglas SD; Kaufman D; Sison AV; Polansky M; Lischner HW; Kozbor D
    J Immunol; 1999 Apr; 162(7):4355-64. PubMed ID: 10201969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of HIV-specific cell-mediated cytotoxicity in the peripheral blood from infected children.
    Buseyne F; Blanche S; Schmitt D; Griscelli C; Rivière Y
    J Immunol; 1993 Apr; 150(8 Pt 1):3569-81. PubMed ID: 8096852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
    Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
    J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-reactive cytotoxic T lymphocytes against human immunodeficiency virus type 1 protease and gamma interferon-inducible protein 30.
    Mason RD; Bowmer MI; Howley CM; Grant MD
    J Virol; 2005 May; 79(9):5529-36. PubMed ID: 15827167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
    Schmitt-Haendle M; Bachmann O; Harrer E; Schmidt B; Bäuerle M; Harrer T
    Viral Immunol; 2005; 18(4):627-36. PubMed ID: 16359229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities.
    Koup RA; Pikora CA; Luzuriaga K; Brettler DB; Day ES; Mazzara GP; Sullivan JL
    J Exp Med; 1991 Dec; 174(6):1593-600. PubMed ID: 1744586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-7 enhancement of antigen-driven activation/expansion of HIV-1-specific cytotoxic T lymphocyte precursors (CTLp).
    Ferrari G; King K; Rathbun K; Place CA; Packard MV; Bartlett JA; Bolognesi DP; Weinhold KJ
    Clin Exp Immunol; 1995 Aug; 101(2):239-48. PubMed ID: 7544247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-specific cytotoxic cell frequencies measured directly ex vivo by the Lysispot assay can be higher or lower than the frequencies of IFN-gamma-secreting cells: anti-HIV cytotoxicity is not generally impaired relative to other chronic virus responses.
    Snyder-Cappione JE; Divekar AA; Maupin GM; Jin X; Demeter LM; Mosmann TR
    J Immunol; 2006 Feb; 176(4):2662-8. PubMed ID: 16456029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased soluble CD8 (sCD8) in human immunodeficiency virus 1-infected children in the first month and year of life.
    Gesner M; Di John D; Krasinski K; Borkowsky W
    Pediatr Infect Dis J; 1994 Oct; 13(10):896-8. PubMed ID: 7854890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-specific cytotoxic T-lymphocyte activity in immunologically normal HIV-infected persons.
    Bernard NF; Pederson K; Chung F; Ouellet L; Wainberg MA; Tsoukas CM
    AIDS; 1998 Nov; 12(16):2125-39. PubMed ID: 9833853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different effects of Nef-mediated HLA class I down-regulation on human immunodeficiency virus type 1-specific CD8(+) T-cell cytolytic activity and cytokine production.
    Tomiyama H; Akari H; Adachi A; Takiguchi M
    J Virol; 2002 Aug; 76(15):7535-43. PubMed ID: 12097566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effector HIV-specific cytotoxic T-lymphocyte activity in long-term nonprogressors: associations with viral replication and progression.
    Keoshkerian E; Ashton LJ; Smith DG; Ziegler JB; Kaldor JM; Cooper DA; Stewart GJ; Ffrench RA
    J Med Virol; 2003 Dec; 71(4):483-91. PubMed ID: 14556259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytotoxic T lymphocyte activity and CD8 subpopulations in children at risk of HIV infection.
    Aldhous MC; Watret KC; Mok JY; Bird AG; Froebel KS
    Clin Exp Immunol; 1994 Jul; 97(1):61-7. PubMed ID: 8033422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection.
    Musey L; Hughes J; Schacker T; Shea T; Corey L; McElrath MJ
    N Engl J Med; 1997 Oct; 337(18):1267-74. PubMed ID: 9345075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
    Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
    J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic T lymphocyte lines specific for human immunodeficiency virus type 1 Gag and reverse transcriptase derived from a vertically infected child.
    McFarland EJ; Curiel TJ; Schoen DJ; Rosandich ME; Schooley RT; Kuritzkes DR
    J Infect Dis; 1993 Mar; 167(3):719-23. PubMed ID: 7680062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.